Adial Pharmaceuticals, Inc ADIL
$3.98
-17.08%
at last close
Market Cap$8.71 million
P/E Ratio—
Div Yield—
Volume100.7K
52-Week Range
$1.31$18.90
Key Stats
- Today's Range
- $3.70 – $4.87
- 50-Day Range
- $2.11 – $5.17
- 52-Week Range
- $1.31 – $18.90
- Volume
- 101K shs
- Average Volume
- 58K shs
- Market Cap
- $8.71 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 2.34
- Price / Sales
- —
Short Interest
- Short Interest
- 0.00%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-7,770,762
- Net Margin
- —
- Return on Equity
- -209.05%
- Debt-to-Equity
- —
About Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Related Stocks
Compare head-to-head: ADIL vs LLY·ADIL vs JNJ·ADIL vs ABBV·ADIL vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.